TestDynamics raises $9M to vet medical imaging AI
What's the deal? TestDynamics has raised a $9 million Series A to expand its platform for evaluating medical imaging algorithms, chief executive officer Lior Eshel told Axios. The company acts as a middleman, aggregating multiple diagnostic AI tools under one interface for radiologists.
Why now? AI vendors are proliferating, and health systems increasingly need ways to vet them. By Eshel's own account, only 5% of US hospitals currently use AI — a gap TestDynamics aims to close with simpler workflows.
What's the endgame? TestDynamics handles IT security, legal integrations, and backend operations so hospitals can deploy and switch between algorithms as needed. Eshel founded the company after his father was misdiagnosed with lung cancer, exposing the backlogs facing overworked radiologists.
What could go wrong? The company sits in a crowded field alongside rivals like CARPL.ai, which raised $10 million in July for a similar deployment platform, and workflow players such as Aidoc. Its significance will hinge on evidence of clinical adoption and measurable value for providers.
The signal: Investors are betting not just on individual diagnostic models, but on the infrastructure that helps providers integrate, oversee, and compare multiple tools — a platform layer gaining traction as hospital AI adoption slowly expands.
Read more: Axios
Image credit: "Nuclear Medicine in Cuba (08010598)" by IAEA Imagebank, licensed under CC BY 2.0